Covid-19 Test Management Platform

Covid-19测试管理平台是一个基于分布式账本技术（DLT）的统一平台，面向测试套件供应商、实验室、数据科学家、公共卫生从业人员和政策制定者。它将由基于移动的应用程序、桌面控制台和平台集成在一起，提供端到端整理、管理、记录和向用户交付测试数据的过程。测试管理平台为测试各方提供了测试的全过程和渠道。这对整个国家、个人和企业都有好处。该系统将利用快速DLT提供的不变性、可用性和帐户结构来提供：稳定的数据，一旦上传是不可变和匿名的。对数据的选择访问——用户将能够根据帐户权限有选择地委派对测试数据的访问。测试套件供应商将能够端到端跟踪每个测试套件。实验室将能够安全、快速地将测试结果直接发送到用户的应用程序帐户5。分布式账本的连接性允许在不增加成本的情况下大规模部署系统。该平台将通过安全的互联网连接进行访问。所选择的DLT快速，可扩展，具有免费交易和数据记录，利用现成的服务器，不像当前的区块链挖矿节点那样能源密集。该平台适用于任何测试，因此可以在最小的重新配置要求下重复使用。我们认为，该平台将对COVID-19疫苗和疗法的跟踪、检测、了解和开发的合作努力产生积极影响。该平台还可作为追踪其他大流行病和传染病的基础。

Covid-19 Test Management PlatformIs a distributed ledger technology (DLT) based unified platform for test kit suppliers, laboratories, data scientists, public health practitioners and policymakers. It will consist of a mobile based application, desktop consoles and platform integrated together to deliver an end to end process of collating, managing, recording and delivering test data to users. The test management platform provides the whole process of testing and a channel for the parties included. This will help the nation, individuals and companies as a whole.The system will leverage the immutability, availability and account structures offered by a fast DLT to offer:1. Stable data that is immutable and anonymous once uploaded2. Selected access to data - Users will be able to selectively delegate access to their test data based on account permissions3. Test kit suppliers will be able to track each test kit end to end4. Laboratories will be able to deliver test results securely and quickly directly to the user's application account5. The connectedness of the Distributed Ledger allows for large scale rollout of the system without accelerating costs. The platform will be accessible through secure internet connections6. The selected DLT is fast, scalable with free transactions and data recording, utilising off the shelf servers that are not as energy intensive as current blockchain mining nodesThe platform is suitable for any testing and is therefore reusable with minimum reconfiguration requirement. We submit that this platform will have a positive impact on the collaborative effort of tracking through testing, understanding and the development of vaccines and therapies for COVID-19\. This platform can also form the basis of tracking other pandemics and infectious diseases.